Hot Deals:
adtech 45.00 (4.65 %) agarwal bolts 1,200.00 (0.00 %) amol minechem 601.00 (0.17 %) anand i-power 20.00 anglo french drugs 745.00 (-0.67 %) apl metals 41.00 (2.24 %) arkfin investments 50.00 arohan 145.00 (3.57 %) assam carbon 200.00 (2.56 %) atlas copco 10,000.00 (1.01 %) auckland international 129.00 (-0.77 %) av thomas 16,800.00 (0.00 %) axles 315.00 (3.96 %) balmer lawrie 202.00 (1.00 %) bharat hotels 280.00 (1.82 %) bima mandi 500.00 (-10.71 %) bira 605.00 (-0.82 %) boat 1,275.00 (2.00 %) c & s electric 555.00 (0.91 %) cable corporation 13.10 (0.77 %) capgemini 11,400.00 (-0.87 %) care health 180.00 (-2.70 %) carrier aircon 390.00 (2.63 %) cial 250.00 (2.04 %) csk 174.00 (-1.14 %) dalmia refract 152.00 (1.33 %) dfm foods 467.00 dsp merrill lynch 1,000.00 east india pharma 39.00 (-2.50 %) eaton fluid 425.00 (2.66 %) electronica plastic 2,100.00 (-0.99 %) elgi ultra 400.00 elofic 2,070.00 (-1.43 %) esl steel 30.00 (3.45 %) fincare business 65.00 (1.56 %) fincare sfbl 202.00 (1.00 %) finopaytech 155.00 (-3.13 %) flipkart india 231,001.00 (0.00 %) frick india 10,100.00 (-1.94 %) gkn driveline 1,300.00 (4.00 %) go digit general insurance ltd 354.00 (1.14 %) godavari bio 71.00 (1.43 %) hdb financial 825.00 (-0.60 %) hdfc ergo 370.00 (1.70 %) hdfc securities 10,650.00 (0.47 %) hella india 810.00 (1.25 %) hero fincorp 1,525.00 (1.67 %) hexaware 780.00 (0.39 %) hicks 1,450.00 (2.11 %) hira ferro 155.00 (3.33 %) honeywell electrical 3,900.00 (2.63 %) ikf finance 210.00 (-2.78 %) incred financial 109.00 (3.81 %) incred holdings 120.00 (8.11 %) india carbon 900.00 (6.01 %) india exposition 135.00 (-0.74 %) indian potash 3,100.00 (3.33 %) indo alusys 25.75 (-0.96 %) indofil 700.00 (1.45 %) infinite computer 405.00 (1.25 %) inkel 17.00 (6.92 %) ixigo 145.00 (3.57 %) jana small finance bank 75.00 kel 615.00 (-1.60 %) kial 125.00 (1.63 %) klm axiva 15.00 (-6.83 %) kurlon limited 625.00 (2.46 %) lava 80.00 (-3.61 %) mahindra rural mrhfl 100.00 manipal housing 72.50 (0.69 %) manjushree technopack 1,000.00 (-0.99 %) martin & harris 990.00 (7.03 %) merino 3,450.00 (4.55 %) minosha 282.00 (0.71 %) mitsubishi heavy 207.00 (-0.48 %) mkcl 414.00 (0.98 %) mobikwik 595.00 (-1.65 %) mohan meakin 1,920.00 (1.05 %) mohfl 13.50 (-1.82 %) msei 1.35 (-6.90 %) msil 41.00 (-2.38 %) nayara energy 410.00 (2.50 %) nayara energy ncd 285.00 (1.79 %) ncdex 275.00 ncl buildtek 265.00 (1.15 %) ncl holdings 71.00 (1.43 %) nsdl 700.00 nse 4,300.00 (1.18 %) orbis financial 255.00 (2.41 %) oswal minerals 60.10 (-1.48 %) otis 3,750.00 (-1.32 %) oyo 65.00 (-3.70 %) panasonic appliances 211.00 (0.48 %) paymate india 530.00 (1.92 %) pharmeasy 9.50 (0.00 %) pharmed limited 470.00 (4.21 %) philips domestic 575.00 (3.60 %) philips india 925.00 (0.54 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 300.00 (-1.64 %) rapido 16,650.00 (0.03 %) rasoi 31,500.00 (0.32 %) reliance gic 410.00 (2.50 %) resins plastics 415.00 (-1.89 %) ring plus aqua 405.00 (0.25 %) rrl 1,275.00 (2.00 %) sab miller 380.00 (1.33 %) sbi amc 1,585.00 (1.93 %) sbi general insurance 600.00 (3.45 %) scottish assam 440.00 (-1.35 %) shriram life 261.00 (0.38 %) sigachi laboratories 36.00 (-2.70 %) signify 1,350.00 (-2.17 %) smile microfinance 54.00 (3.85 %) sportskeeda 3,303.00 sterlite power 510.00 (-1.92 %) studds 999.00 (-0.10 %) svsml 330.00 (-0.90 %) swiggy 361.00 (0.28 %) t stanes 755.00 (2.72 %) tata capital 795.00 (0.63 %) teesta agro 77.00 (-6.21 %) trl krosaki 1,300.00 (-1.89 %) utkarsh coreinvest 330.00 (-0.90 %) vadilal dairy 10.00 vikram solar 250.00 (-1.96 %) waree energies 1,875.00 (1.35 %)
×

DEYS Medical Ltd Annual Reports, Balance Sheet and Financials

Company Name
DEYS Medical Stores Manufacturing Limited
Scrip Name
DEYS Medical
Last Traded Price
400.00
+ 0.00 %
Sector
Pharma
PAN No.
AABCD1608D
Face Value
10
No. of Outstanding Shares
851,186
EPS
82.121
PE ratio
4.871
Market Capitalization
34.05 Crore
Book value
708.61
P/BV
0.5645
ISIN No.
INE00H901015
Available on
nsdl
ROFR Require
No

DEYS Medical Stores Manufacturing Limited Balance Sheet (Rs in Thousands)

PARTICULARS

2020

2019

EQUITY AND LIABILITIES

 

 

Shareholders ' Funds

 

 

Share Capital

8512

8512

 Reserve & Surplus

594647

525950

 Non Current Liabilities :

 

 

 Long-Term Borrowings

13695

15723

Deferred Tax Liabilities (Net)

1903

1874

 Long-Term Provisions

71665

47314

 Current Liabilities

 

 

 Short-Term Borrowings

7075

5161

Trade Payables

56998

62782

Other Current Liabilities

63214

61236

 Short-Term Provisions

851

1539

Total

814754

726343

ASSETS

 

 

Non-Current Assets :

 

 

Properties, Plant and Equipment

 

 

Tangible Assets

58077

51119

 Long-Term Loans and Advances

74119

45744

Other Non-Current Asset

150145

134950

 Current Assets

 

 

 inventories

235587

224482

Trade Receivables

116226

102633

 Cash and Cash Equivalents

133087

114252

 Short-Term Loans and Advances

47513

53163

Total :

814754

726343

DEYS Medical Stores Manufacturing Limited Profit& Loss Statement (Rs in Thousands)

PARTICULARS

2020

2019

INCOME

 

 

Revenue from operation

1090109

1052123

Other income

15453

10229

TOTAL REVENUE

1105562

1062352

EXPENDITURE

 

 

Cost of Materials consumed

325643

318938

Purchases of Traded Goods

67434

65758

Changes in inventories of Finished Goods

8358

7407

Work-in-Progress and Traded Goods

 

 

  Employee benefits expense

368285

334656

Finance costs

1568

1075

Depreciation & Amortization expense

6217

6528

Other expenses

      250551

243836

TOTAL EXPENSES

1011340

963384

Profit before exceptional and extraordinary items and tax

94222

98968

Profit before extraordinary items and tax

94222

98968

Profit before tax

94222

98968

TAX EXPENSES

 

 

Current Tax

24351

 28827

 Deferred Tax charge / (Credit)

29

149

Tax adjustments related to previous year

 -

1677

Profit for the Period

69900

68613

Earning per equity share :

 

 

 Basic

82.12

80.61

 Diluted

82.12

80.61

DEYS Medical Stores Manufacturing Limited Consolidated Cash Flow Statement (Rs in Thousands)

PARTICULARS

2020

2019

Cash Flow from Operating Activities

 

 

Net Profit before tax & Extra ordinary items

94222

98968

Adjustment for

 

 

Depreciation

6217

6528

interest income

15169

10198

Finance Costs

1568

1075

Operating Profit Before Working Capital Changes

86838

96373

Adjustment for

 

 

Decrease/(increase) in Trade &
Other Receivables

7943

19421

Decrease/(increase) in Inventories

11105

3774

(Decrease)/increase in Trade and other payables

1892

17074

Cash generated from operation

65898

90252

income Tax Paid (net of refunds)

28322

16740

Net Cash from Operating Activities

37576

73512

Cash Flow from investing Activities :

 

 

Purchase of Fixed Assets

13527

2445

interest income

15169

10198

Net Cash used in investing Activities

1642

7753

 Cash Flow from Financing Activities

 

 

Long-term Loans & Advances Availed/(Paid) (Net)

17276

67170

Finance Cost

1568

1075

Dividend Paid

1277

851

Tax on Dividend

262

175

Net Cash used in Financing Activities

20383

69271

Net increase(decrease) in Cash & Cash Equivalents

18835

11994

Cash & Cash Equivalents at the beginning of the year

114252

102258

Cash & Cash Equivalents at the closing of the year

133087

114252

Certainly, here is a summary of the Cash Flow Statement for the years 2019 and 2020:

Cash Flow from Operating Activities:

1. Net Profit before tax & Extraordinary items: In 2020, the net profit before tax and extraordinary items was 94,222 rupees, slightly lower than the 98,968 rupees in 2019.

2. Adjustments:

   Depreciation: The depreciation in 2020 was 6,217 rupees, compared to 6,528 rupees in 2019.

   Interest Income and Finance Costs: Interest income increased from 10,198 to 15,169 rupees, while finance costs rose from 1,075 to 1,568 rupees in 2020.

3. Operating Profit before Working Capital Changes: The operating profit before working capital changes decreased from 96,373 to 86,838 rupees in 2020.

4. Working Capital Changes:

   Decrease/(Increase) in Trade & Other Receivables: Trade and other receivables decreased by 7,943 rupees in 2020, compared to an increase of 19,421 rupees in 2019.

   Decrease/(Increase) in Inventories: Inventories increased by 11,105 rupees in 2020, while in 2019, there was an increase of 3,774 rupees.

   (Decrease)/Increase in Trade and other payables: Trade and other payables increased by 1,892 rupees in 2020, compared to an increase of 17,074 rupees in 2019.

5. Cash generated from operation: The cash generated from operations was 65,898 rupees in 2020, down from 90,252 rupees in 2019.

6. Income Tax Paid: The net income tax paid (net of refunds) increased from 16,740 rupees in 2019 to 28,322 rupees in 2020.

7. Net Cash from Operating Activities: The net cash from operating activities was 37,576 rupees in 2020, lower than the 73,512 rupees in 2019.

Cash Flow from Investing Activities:

1. Purchase of Fixed Assets: The Company invested 13,527 rupees in fixed assets in 2020, significantly higher than the 2,445 rupees in 2019.

2. Interest Income: Interest income from investing activities was 15,169 rupees in both years.

3. Net Cash used in Investing Activities: The net cash used in investing activities was 1,642 rupees in 2020, compared to 7,753 rupees in 2019.

Cash Flow from Financing Activities:

1. Long-term Loans & Advances Availed/(Paid) (Net): The net amount of long-term loans and advances availed or paid was 17,276 rupees in 2020 and 67,170 rupees in 2019.

2. Finance Cost: Finance costs increased from 1,075 rupees in 2019 to 1,568 rupees in 2020.

3. Dividend Paid: Dividend payments increased from 851 rupees in 2019 to 1,277 rupees in 2020.

4. Tax on Dividend: The tax on dividends increased from 175 rupees in 2019 to 262 rupees in 2020.

5. Net Cash used in Financing Activities: The net cash used in financing activities was 20,383 rupees in 2020, compared to 69,271 rupees in 2019.

Net Increase/ (Decrease) in Cash & Cash Equivalents:

1. Net Increase/ (Decrease) in Cash & Equivalents: The net increase in cash and equivalents was 18,835 rupees in 2020, higher than the 11,994 rupees in 2019.

Cash & Cash Equivalents at the Beginning and Closing of the Year:

1. Cash & Cash Equivalents at the Beginning of the Year: The cash and cash equivalents at the beginning of the year were 114,252 rupees in 2020 and 102,258 rupees in 2019.

2. Cash & Cash Equivalents at the Closing of the Year: The cash and cash equivalents at the closing of the year increased to 133,087 rupees in 2020, compared to 114,252 rupees in 2019.

Below are the Financial Ratios

PARTICULARS

2017

EBITDA

 33.13 %

Net worth

 14.64 %

Debt/Equity Ratio

0.15

Return on Equity

13.23%

Total Assets

 4.89 %

Fixed Assets

 -8.49 %

Current Assets

 13.90 %

Current Liabilities

 -2.84 %

Trade Receivables

 7.38 %

Trade Payables

 -8.16 %

Current Ratio

4.62

Certainly! Let 's delve into the financial particulars for the year 2017 and provide a detailed explanation point-wise:

1. EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization):

   Percentage: The EBITDA margin is 33.13%, indicating that 33.13% of the revenue is converted into EBITDA. This margin is a measure of operational profitability.

2. Net worth:

   Percentage: Net worth represents 14.64% of the company 's total equity and is a measure of the company 's overall financial health. A higher net worth percentage implies a more robust financial position.

3. Debt/Equity Ratio:

   Ratio: The Debt/Equity ratio is 0.15, suggesting that the company is financed with a low level of debt compared to equity. This implies a lower financial risk and indicates a conservative financial structure.

4. Return on Equity (ROE):

   Percentage: The Return on Equity is 13.23%, indicating that the company generates a return of 13.23% on shareholders ' equity. This metric reflects the efficiency of using equity to generate profits.

5. Total Assets:

   Percentage: Total assets have grown by 4.89%, showcasing an increase in the company 's overall asset base. This growth could be attributed to various factors such as investments, acquisitions, or organic expansion.

6. Fixed Assets:

   Percentage: Fixed assets show a decline of -8.49%, suggesting a reduction in long-term assets. This could be due to asset sales, depreciation, or a shift in the company 's investment strategy.

7. Current Assets:

   Percentage: Current assets have increased by 13.90%, indicating higher liquidity or short-term assets. This may positively impact the company 's ability to meet its short-term obligations.

8. Current Liabilities:

   Percentage: Current liabilities have decreased by -2.84%, suggesting a potential improvement in the company 's ability to meet its short-term obligations. However, a thorough analysis of the components of current liabilities is needed for a comprehensive understanding.

9. Trade Receivables:

   Percentage: Trade receivables have increased by 7.38%, which could impact cash flow and liquidity. It 's important to monitor and manage receivables to ensure timely cash collection.

10. Trade Payables:

    Percentage: Trade payables have decreased by -8.16%, potentially impacting the company 's relationships with suppliers. Careful management of payables is crucial for maintaining good vendor relationships.

11. Current Ratio:

    Ratio: The current ratio is 4.62, indicating a healthy liquidity position. A ratio above 1 suggests the company has more short-term assets than short-term liabilities, reflecting a strong ability to cover its immediate obligations.

Annual Report

DEYS Medical Stores Annual Report 2019-20

Download
Wealth Wisdom - WWIPL
Support Megha Support Neha